SNCA and Parkinson disease: The study demonstrates that ASO-mediated suppression of SNCA prevented and reversed the progression of α-Syn-mediated pathology in rodent transmission models of PD, demonstrating the potential of SNCA ASOs as a therapy for PD patients.